Literature DB >> 22482118

Definition of post-thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations.

N A Goldenberg1, L R Brandão, J Journeycake, S R Kahn, P Monagle, S Revel-vilk, A Sharathkumar, A K C Chan.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22482118     DOI： 10.1111/j.1538-7836.2011.04594.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  14 in total

1.  The phase 3 pediatric anticoagulant era.

Authors:  Neil A Goldenberg; Brian R Branchford
Journal:  Blood       Date:  2020-02-13       Impact factor: 22.113

2.  Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.

Authors:  Leonardo R Brandão; Manuela Albisetti; Jacqueline Halton; Lisa Bomgaars; Elizabeth Chalmers; Lesley G Mitchell; Ildar Nurmeev; Pavel Svirin; Tomas Kuhn; Ondrej Zapletal; Igor Tartakovsky; Monika Simetzberger; Fenglei Huang; Zhichao Sun; Jörg Kreuzer; Savion Gropper; Martina Brueckmann; Matteo Luciani
Journal:  Blood       Date:  2020-02-13       Impact factor: 22.113

3.  Outcomes in children with deep vein thrombosis managed with percutaneous endovascular thrombolysis.

Authors:  Christopher E Dandoy; Kamlesh U Kukreja; Ralph A Gruppo; Manish N Patel; Cristina Tarango
Journal:  Pediatr Radiol       Date:  2014-11-07

4.  Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.

Authors:  N A Goldenberg; T Abshire; P J Blatchford; L Z Fenton; J L Halperin; W R Hiatt; C M Kessler; J M Kittelson; M J Manco-Johnson; A C Spyropoulos; P G Steg; N V Stence; A G G Turpie; S Schulman
Journal:  J Thromb Haemost       Date:  2015-08-11       Impact factor: 5.824

Review 5.  The post-thrombotic syndrome.

Authors:  Susan R Kahn
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.

Authors:  Neil A Goldenberg; John M Kittelson; Thomas C Abshire; Marc Bonaca; James F Casella; Rita A Dale; Jonathan L Halperin; Frances Hamblin; Craig M Kessler; Marilyn J Manco-Johnson; Robert F Sidonio; Alex C Spyropoulos; P Gabriel Steg; Alexander G G Turpie; Sam Schulman
Journal:  JAMA       Date:  2022-01-11       Impact factor: 157.335

7.  The post-thrombotic syndrome: a 2012 therapeutic update.

Authors:  Jean-Philippe Galanaud; Susan R Kahn
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-04

Review 8.  Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: A systematic review and meta-analysis.

Authors:  Ayesha Zia; Joy Russell; Ravi Sarode; Surendranath R Veeram; Shellie Josephs; Kendra Malone; Song Zhang; Janna Journeycake
Journal:  Thromb Res       Date:  2017-10-07       Impact factor: 3.944

9.  Reduced Physical Activity Levels in Children after a First Episode of Acute Venous Thromboembolism.

Authors:  Ayesha Zia; Zhuo Yang; Song Zhang; Tony Babb
Journal:  J Pediatr       Date:  2020-04       Impact factor: 4.406

10.  Physical activity in children at risk of postthrombotic sequelae: a pilot randomized controlled trial.

Authors:  Rida Hasan; Maria Hanna; Song Zhang; Kendra Malone; Elizabeth Tong; Niavana Salas; Ravi Sarode; Janna Journeycake; Ayesha Zia
Journal:  Blood Adv       Date:  2020-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.